Can you explain the diagnosis of lichenoid interface dermatitis with prominent papillary dermal melanophages and eosinophils on a punch biopsy of the right lateral superior chest, including the differential diagnosis and recommended clinical correlation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Understanding Your Biopsy Diagnosis: Lichenoid Interface Dermatitis

Your biopsy shows a pattern of skin inflammation where immune cells are attacking the junction between the outer and inner layers of your skin, with specific features that narrow the diagnosis to either a drug-induced reaction or a pigmentary disorder called lichen planus pigmentosus.

What the Pathology Report Means

Lichenoid Interface Dermatitis

This describes inflammation at the dermal-epidermal junction (where your skin's outer and inner layers meet) with a band-like pattern of lymphocytes (immune cells) causing damage to keratinocytes (skin cells) 1, 2. This is not a specific disease but rather a pattern seen in multiple conditions.

Prominent Papillary Dermal Melanophages

These are cells in the upper dermis that have engulfed melanin pigment, appearing as the skin attempts to clear damaged pigment-producing cells. This finding is characteristic of chronic interface dermatitis and contributes to the pigmentary changes you may see clinically 3.

Eosinophils Present

The presence of eosinophils (a type of white blood cell) is particularly important. While classic lichen planus typically has few eosinophils, their presence here strongly suggests:

  • Lichenoid drug eruption (most likely) 4, 5
  • Hypertrophic variants of lichen planus 5
  • Immunotherapy-related lichenoid reactions if you're on cancer treatment 6, 7

The Two Main Diagnostic Possibilities

1. Lichenoid Drug Eruption (Most Common)

This occurs when medications trigger an immune reaction in your skin 6, 8, 7.

Key medications that cause this pattern include:

  • Immune checkpoint inhibitors (anti-PD-1, anti-PD-L1, anti-CTLA-4) used for cancer treatment 6, 7, 4
  • Antimalarials (hydroxychloroquine)
  • Beta-blockers
  • ACE inhibitors
  • NSAIDs
  • Thiazide diuretics

Clinical features to look for:

  • Violaceous (purple-red) papules and plaques on trunk and extremities 6
  • Significant itching 6
  • Onset typically 6-12 weeks after starting the medication 6
  • May involve oral mucosa with erosions and white lines 6

2. Lichen Planus Pigmentosus

A variant of lichen planus that primarily affects pigmentation, more common in darker skin types, presenting as dark brown to gray-brown patches, often on sun-exposed areas.

What You Need to Do Next: Clinical Correlation

Your dermatologist must now correlate these findings with your clinical presentation:

  1. Medication review: Document ALL medications started in the past 3-6 months, including over-the-counter drugs and supplements

  2. Clinical examination details needed:

    • Distribution pattern (trunk, extremities, sun-exposed areas)
    • Color of lesions (violaceous vs. brown/gray)
    • Presence of scale or lack thereof
    • Oral mucosa examination for white striae or erosions
    • Check for nail involvement
  3. Timing assessment: When did lesions appear relative to any new medications?

  4. Cancer treatment history: Are you receiving or have you recently received immunotherapy? 6, 7, 4

Treatment Approach

If this is a drug-induced lichenoid eruption, management follows this algorithm 6, 7:

First-Line Treatment

  • High-potency topical corticosteroids (clobetasol 0.05% or fluocinonide 0.05% cream/ointment) 6
  • Alternative: Tacrolimus 0.1% ointment 6
  • Use cream/lotion/ointment for body lesions, gel for mucosal disease, solution for scalp 6

Additional Measures

  • Oral antihistamines for pruritus control 6
  • Oral prednisone if topical therapy insufficient 6
  • Narrow-band UVB phototherapy if available and appropriate 6

For Immunotherapy-Related Cases

If you're on cancer treatment, do NOT stop immunotherapy without oncology consultation 7. Most cases respond to topical steroids without requiring treatment interruption 4. Only severe cases (grade 3-4) require systemic steroids and potential treatment hold 7.

If Drug-Induced

Withdrawal of the offending medication is essential for resolution, though improvement may take weeks to months even after stopping the drug 6.

Important Caveats

  • Eosinophils in lichenoid dermatitis strongly favor drug reaction over idiopathic lichen planus 4, 5
  • The presence of melanophages indicates chronicity and explains any pigmentary changes you see 3
  • Do not confuse this with melanoma: The pathologist has ruled out malignancy, but the pigmentation and dermal changes can sometimes raise concern 3
  • If you're on immunotherapy for cancer, this reaction may paradoxically indicate good tumor response, particularly if you develop vitiligo-like changes 8

When to Worry

Seek immediate attention if you develop:

  • Widespread blistering or skin peeling
  • Mucosal erosions affecting eating or drinking
  • Fever or systemic symptoms
  • Rapid progression despite treatment

Your next step is to review your complete medication list with your dermatologist to identify the likely culprit and determine whether medication adjustment is needed while initiating appropriate topical therapy 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.